• DevelopingMagnitude 7 earthquake reported in China; GDACS estimates 10,000 in MMI VII+ area — 2 sources
  • New storyCrash on Dixie Highway in Crestview Hills closes I-275 exit ramp
  • DevelopingNWS warns of severe thunderstorm with 60 mph gusts, large hail in parts of Arizona — 3 sources
  • DevelopingNWS warns of severe thunderstorm with 60 mph gusts, large hail in parts of Arizona — 2 sources
  • DevelopingMagnitude 7 earthquake reported in China; GDACS estimates 10,000 in MMI VII+ area — 1 source
  • New storyNWS warns of severe thunderstorm with 60 mph gusts, large hail in parts of Arizona
  • RenderingHurricane Utah flooding forces Gould Wash and WillowWind evacuations
  • New storyOne dead after crash into tree on Carl Baker Road in Starr, coroner says
  • New storyNWS warns of flash flooding in Fresno area through 6:15 p.m. PDT
  • New storyNWS warns of severe thunderstorm near Solomon with 60 mph gusts and quarter-size hail

Continuing story · 1 report

Novo Nordisk's lawsuit over Eli Lilly GLP-1 ads

First aired Latest aired

Gone quiet since

Where it stands

Novo Nordisk has sued Eli Lilly in federal court, alleging its direct-to-consumer GLP-1 drug ads make false and misleading dosing comparisons; Lilly says the ads are truthful. No court ruling, settlement or other resolution is reported, so the case remains open.

Explore with HeyDex

Story trackerDay 1

1 report11 outlets11 sources1 video

  • No dated events yet
    1. Update 1Four Drugs, One Courtroom: Novo Nordisk Takes Eli Lilly to Trial Over GLP-1 Ads

    The story so far

    1. Update 1

      Four Drugs, One Courtroom: Novo Nordisk Takes Eli Lilly to Trial Over GLP-1 Ads

      A New Jersey federal complaint says Lilly's Zepbound and Mounjaro ads stack the dosing deck against Wegovy and Ozempic. The market they share is reshaping the industry.

      Still open after this report

      • Any verbatim Lilly on-the-record statement beyond the general "truthful and based on the best available scientific evidence" framing. The source file does not include one.
      • How the court will treat the question of which doses are properly comparable, and which clinical trials it considers current.
      • Whether the case produces a settlement, a ruling on the injunction, or a long discovery fight.

    History

    1. Opened1 report

    Who's involved

    Places

    • CopenhagenCopenhagen, Denmark1 report
    • IndianapolisIndianapolis, IN, USA1 report
    • US District Court for the District of New Jersey50 Walnut St #4015, Newark, NJ 07102, USA1 report

    Every outlet we read on this story

    11 sources11 outlets1 video